Pet Health

Elanco Demo-Cast: Credelio® CAT (lotilaner)

Elanco is organizing an online informational session, dubbed a "Demo-Cast," scheduled for December 9, 2025. This event is specifically designed to showcase Credelio® CAT, a product containing lotilaner, aimed at veterinary professionals. The webinar seeks to provide comprehensive details about this feline health solution, offering insights into its application and efficacy. Attendees will have the opportunity to delve into the specifics of this new offering, understanding how it can benefit their practice and the well-being of their feline patients.

The upcoming Demo-Cast by Elanco is set to take place on December 9, 2025, at 1 p.m. Eastern Time, which corresponds to 10 a.m. Pacific Time. This virtual gathering focuses on Credelio® CAT, highlighting the lotilaner compound as its key active ingredient. The session is targeted towards veterinarians and animal health practitioners who are interested in staying informed about the latest advancements in parasiticides for cats. Participants will learn about the scientific background, clinical applications, and practical benefits of integrating Credelio® CAT into their treatment protocols.

Registration for the Elanco Demo-Cast on Credelio® CAT is currently open. Prospective attendees can sign up through the provided online portal to secure their spot for this informative webinar. The event promises to be a valuable resource for veterinary professionals seeking to enhance their knowledge of effective parasite management strategies for cats. By attending, they can gain a deeper understanding of lotilaner's mechanism of action and how Credelio® CAT stands out in the market.

The webinar aims to cover various aspects of Credelio® CAT, including its safety profile, dosage guidelines, and broad-spectrum efficacy against common feline parasites. It's an essential event for any veterinary clinic looking to optimize its approach to preventive care and treatment for their feline clientele. Don't miss this chance to engage with industry experts and discover the potential of Credelio® CAT in improving animal health outcomes.

Elanco invites veterinary practitioners to attend its upcoming Demo-Cast on Credelio® CAT (lotilaner) on December 9, 2025. This webinar will provide a detailed overview of the product, including its benefits and applications in feline parasite control. Register today to gain valuable knowledge and insights from the comfort of your home or office.

Enhancing Client Loyalty: Nine Strategies for Veterinary Practices

Cultivating strong emotional bonds with pet owners is paramount for ensuring their continued loyalty to veterinary practices. Simon T. Bailey, a keynote speaker focusing on customer engagement, underscores that decisions are primarily driven by emotions, advocating for veterinary professionals to share their compassion alongside their scientific expertise. This emotional connection transcends transactional interactions, transforming a clinic visit into a meaningful experience that directly influences patient well-being and client engagement.

Implementing thoughtful, personalized touches can significantly enhance client satisfaction and retention. Strategies such as prominently displaying pet names on welcome boards, celebrating significant milestones with customized boards for puppies, kittens, and senior pets, and incorporating pet photos into medical records all contribute to a more personalized and engaging client experience. Additionally, maintaining client information sheets detailing personal interests allows staff to tailor their approach, demonstrating genuine care and strengthening the human-animal bond. Effective communication, including greeting clients and pets by name and expressing empathy during sensitive appointments, further solidifies trust and rapport. Creating a serene and supportive environment for end-of-life care, through dedicated comfort rooms and thoughtful amenities, can provide immense solace to grieving pet owners. Lastly, handwritten notes and expressing gratitude during checkout leave a lasting positive impression, while providing comprehensive car-side service for discharging hospitalized patients ensures safety and convenience, culminating in a holistic approach that prioritizes emotional connection and exceptional care.

By embracing these client-centric approaches, veterinary practices can build enduring relationships that extend beyond medical necessity. Focusing on empathetic interactions and personalized experiences not only differentiates a clinic but also fosters a community where clients feel valued and understood. Such dedicated efforts empower practices to exceed expectations, cultivating loyalty and ensuring pets receive the best possible care, supported by a compassionate and engaged veterinary team.

See More

Understanding Discospondylitis in Canines: Causes, Symptoms, and Treatment

Discospondylitis represents a serious condition in canines where an infection, either bacterial or fungal, infiltrates the intervertebral discs and adjacent vertebrae of the spine. Unlike spondylosis, which is a degenerative bone disorder, discospondylitis is purely infectious. This ailment can manifest in a single spinal segment or multiple areas simultaneously, posing significant challenges to canine well-being.

Detailed Report on Canine Discospondylitis

The primary route of infection for discospondylitis often begins with the systemic circulation of bacteria or fungi. Pathogens originating from other bodily sites, such as oral cavities, skin, or urinary tracts, can journey through the bloodstream and establish new infectious foci within the dog's spinal discs. A less common but significant cause involves the migration of foreign bodies, like grass awns or foxtails, which can create a pathway for infectious agents to enter and spread. Additionally, severe spinal trauma, including bite wounds, vehicular accidents, or, rarely, complications from back surgery, can predispose a dog to developing this condition.

While any dog breed can be afflicted, large and giant breeds such as Great Danes, German Shepherds, Boxers, Rottweilers, Dobermans, and English Bulldogs are observed to be more susceptible. Factors like chronic skin infections, compromised immune systems, or the use of immunosuppressive medications can further elevate a dog's risk. The clinical presentation of discospondylitis is often non-specific, making early diagnosis challenging. Affected dogs may exhibit pain, stiffness, reluctance to move, avoidance of jumping or climbing stairs, and a sensitive reaction to touch. Other general symptoms include fever, decreased appetite, weight loss, and lethargy. Should the infection lead to disc swelling and subsequent pressure on the spinal cord, neurological deficits such as an unsteady gait, paw dragging, limb weakness, muscle atrophy, and even paralysis can ensue. The specific symptoms often correlate with the precise location of the spinal infection, with the thoracic and lumbar regions being most commonly affected.

The diagnostic process can be protracted due to the non-specific nature of the symptoms. Initial X-rays, while useful, may not reveal definitive bony changes until three to six weeks post-symptom onset, necessitating repeat imaging. More advanced imaging techniques, including myelography, CT scans, MRI, or bone scintigraphy, can facilitate earlier detection and may require referral to a veterinary specialist. Once discospondylitis is suspected, identifying the causative agent through blood and urine cultures is crucial. Brucellosis testing is also a standard procedure. In some instances, a spinal tap to analyze cerebrospinal fluid, performed under anesthesia by a specialist, may be necessary. Direct culturing of the infected disc, though highly invasive, is rarely undertaken.

Treatment typically spans six to 12 months, involving long-term administration of antibiotics or antifungal medications, tailored to the specific pathogen identified through culture and sensitivity testing. Fungal infections generally present a greater challenge to eradicate. Pain management is also a critical component of care to ensure the dog's comfort. Surgical intervention to remove damaged tissue, irrigate the infected area, and relieve spinal cord compression may be considered in severe cases, ideally performed by a board-certified specialist. Most dogs demonstrate clinical improvement within two weeks of commencing treatment. If progress is not observed, a reevaluation of the treatment plan is warranted. Regular X-rays help monitor the healing progression of the spinal bones.

The prognosis for bacterial discospondylitis is generally favorable, with most dogs responding well to treatment, despite potential relapses. Fungal infections carry a more guarded prognosis, with some dogs requiring lifelong medication. Discospondylitis caused by brucellosis is incurable and necessitates lifelong management due to its zoonotic potential. The presence of severe neurological symptoms across all infection types is indicative of a less favorable outcome. Adherence to the full course of medication is paramount for successful recovery, restoring the dog's quality of life.

This information underscores the critical importance of early diagnosis and persistent treatment for canine discospondylitis. As pet owners, recognizing subtle changes in a dog's behavior or mobility, especially in large breeds, and seeking prompt veterinary attention can significantly impact the outcome. The journey through treatment can be long, but with dedicated care, many dogs can regain a comfortable and active life. This highlights the ongoing advancements in veterinary medicine and the need for continued research into effective management strategies for complex canine diseases.

See More